reported that oral administration of D-4F led to a substantial increase in the protective capacity of HDL to protect LDL against oxidation and dramatically reduced atherosclerosis in LDL receptor-null mice but independent of changes in total plasma or HDL-c (56). Here, LDLR is linked to atherosclerosis.